The FDA's Adverse Event Reporting System lists 138 cases of bladder cancer in patients who took at least one
medicine for diabetes between 2004 and 2009. Of the cases, more than a fifth involved users of Takeda Pharmaceutical's Actos. Researchers suggested in Diabetes Care that medical providers "pay careful attention to this possible risk," as the FDA continues reviewing the safety profile of Actos.

Full Story:

Related Summaries